Strengthening our local footprint through the establishment of an office in Bonn, Germany
Since March 2018, PharmaLex is proud to announce the opening of a new office located in Bonn, a major biotech and pharma hub in Germany. To celebrate the opening, we held an evening event on June 27th in an intimate setting of roughly 30 guests from the pharmaceutical and biotech industry. The evening was accompanied by two guest speakers, Prof. Burkhard Sträter giving us insights on New HTA Regulation as well as Horst Kastrup sharing his knowledge on the Falsified Medicines Directive. By opening an office in Bonn we are happy to be closer to our local client base and able to offer them all of our services covering Development Consulting & Scientific Affairs, Regulatory Affairs, Quality Management & Compliance as well as Pharmacovigilance, Epidemiology & Risk Management. We have enjoyed the opportunity to chat, socialize and network with current and also new potential customers and want to thank everyone who came along for making this a great event.